日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hydrogel-mediated tri-modal nanoplatform for localized colorectal cancer therapy via smart chemo-photothermal-radiotherapy

基于水凝胶的三模式纳米平台，通过智能化疗-光热-放疗实现局部结直肠癌治疗

期刊:Journal of Biological Engineering
影响因子:6.5
doi:10.1186/s13036-026-00633-0
Shi, Yanlong; Ding, Sentai; Wang, Zexin; Li, Leping; Wang, Jinshen; Mehdizadeh, Sepehr; Pilehvar, Younes
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Efficacy and safety of Tislelizumab combined with Axitinib as first-line treatment for intermediate- and high-risk metastatic clear-cell renal cell carcinoma

替利珠单抗联合阿昔替尼一线治疗中高危转移性透明细胞肾细胞癌的疗效和安全性

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1618898
Cui, Jie; Xu, Pengyong; Guo, Changying; Guan, Yong; Zhu, Kejia; Ding, Sentai
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review

免疫检查点抑制剂疗法作为肌层浸润性膀胱癌的新辅助治疗：一篇叙述性综述

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000263
Ding, Sentai; Wu, Chenrui; Cao, Jishuang; Lyu, Jiaju
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Expression of HER2 in urothelial carcinoma and its significance

HER2在尿路上皮癌中的表达及其意义

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000249
Chang, Yao; Zhao, Delong; Wang, Zicheng; Zhu, Kejia; Guo, Andong; Cao, Jishuang; Wu, Chenrui; Ding, Sentai
肿瘤
肿瘤免疫
HER2
发表日期：2025
文献求助 收藏

Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients

基于中国专家共识的高级别尿路上皮癌中HER2的表达及disitamab vedotin-tislelizumab联合疗法治疗晚期患者的临床疗效

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1355081
Zhu, Kejia; Chang, Yao; Zhao, Delong; Guo, Andong; Cao, Jishuang; Wu, Chenrui; Guan, Yong; Ding, Sentai
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏

Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics

HER2在尿路上皮癌中的临床意义及其与糖酵解代谢特征的相关性分析

期刊:Frontiers in Molecular Biosciences
影响因子:4
doi:10.3389/fmolb.2024.1521889
Guo, Andong; Wu, Chenrui; Cao, Jishuang; Zhu, Kejia; Ding, Sentai
肿瘤
肿瘤免疫
HER2
代谢
发表日期：2024
文献求助 收藏

Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations

在伴有HRR基因突变的mCRPC患者中，PARP抑制剂联合新型激素疗法一线治疗的真实世界疗效和安全性

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2024.1505163
Guo, Andong; Wu, Chenrui; Cao, Jishuang; Zhu, Kejia; Ding, Sentai
PARP
CRP
免疫/内分泌
发表日期：2024
文献求助 收藏

Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia.

缺氧激活前列腺基质细胞系中的缺氧诱导因子-1α/血管内皮生长因子通路：良性前列腺增生的发病机制

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000233
Zhang Tao, Mao Changlin, Chang Yao, Lyu Jiaju, Zhao Delong, Ding Sentai
细胞生物学
发表日期：2024
文献求助 收藏

Laparoscopy and ureteroscopy cooperative surgery for high burden stones in solitary kidney and ureter in one stage: A case report

腹腔镜和输尿管镜联合手术一次性切除孤立肾和输尿管高负荷结石：病例报告

期刊:
影响因子:
doi:10.3892/etm.2023.11956
Zhu, Kejia; Chang, Yao; Zhao, Delong; Guan, Yong; Ding, Sentai
发表日期：2023
文献求助 收藏

ICSI outcomes for infertile men with severe or complete asthenozoospermia

严重或完全性弱精子症不育男性的ICSI结果

期刊:Basic and Clinical Andrology
影响因子:2
doi:10.1186/s12610-022-00155-x
Chen, Tong; Fan, Demin; Wang, Xianlong; Mao, Changlin; Chu, Yaru; Zhang, Haobo; Liu, Wen; Ding, Sentai; Liu, Qingyong; Yuan, Mingzhen; Lu, Jiaju
发表日期：2022
文献求助 收藏